Connect with us

Hi, what are you looking for?

Jewish Business News


Israeli Brainsway rises on clinical trial success for Parkinson’s disease


Brainsway Ltd. (TASE:BRIN) today reported success in a clinical trial on Parkinson’s disease. The company reported the final results of a double-blind clinical trial to test the effect of its Deep TMS (transcranial magnetic stimulation) device for the treatment of Parkinson’s disease. The trial was conducted at the San Raffaelle Medical center in Milan.

 Brainsway’s share price rose 4.8% in morning trading, following the announcement, to NIS 57.05, giving a market cap of NIS 810 million (about $230 million) .

The study included 60 patients with Parkinson’s disease. Brainway says that all the patients completed the treatment period and that no significant side effects were reported.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

The patients were divided into three groups: those who received real treatment of the motor cortex and prefrontal cortex; those who received real treatment of the motor cortex and placebo treatment of the prefrontal cortex; and those who received placebo treatment of the motor cortex and prefrontal cortex. The assignment of the patients, who received three weekly treatments over four weeks, was random and double-blind (neither the patient nor the researcher knew which group a patient belonged to).

The researchers said that the treatment was found to be safe and resulted in significant clinical improvement among the Parkinson’s patients, and that the results support a subsequent multicenter clinical trial.

Published by Globes [online], Israel business news – 



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.